Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Atrial Late Gadolinium Enhancement in Patients With Repaired Congenital Heart Disease

NCT05241418 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.

NCT NCT05241418
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05241418 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Atrial Late Gadolinium Enhancement in Patients With Repaired Congenital Heart Disease
Lead sponsor
Boston Children's Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
March 23, 2022
Completion date
June 30, 2029
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

congenital heart disease, fibrosis myocardial, fibrosis; heart